Skip to main content
Clinical Trials/IRCT20210819052230N1
IRCT20210819052230N1
Recruiting
Phase 2

Study of the efficacy of memantine as adjunctive therapy with chemotherapy regimen in metastatic colon cancer: A pilot randomized clinical trial

Oroumia University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Oroumia University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • All patients over 18 years of age with metastatic colon cancer

Exclusion Criteria

  • Severe renal failure
  • Liver failure (more than 5\-fold increase in liver enzymes)
  • History of memantine allergy
  • History of seizures
  • Cardiovascular disease
  • Eye diseases
  • Concomitant use of drugs that alter the pH of the urine.

Outcomes

Primary Outcomes

Not specified

Similar Trials